LFST — LifeStance Health Group Inc. price, chart and key statistics

Price data

Price

$12.22

YTD price return

+73.58%

YTD total return

+73.58%

Next earnings

Nov 5, 2026 · Before open

Market cap

4.7B2021-06 10.4B2026-10 4.7B-55.2% over the window

Enterprise value

4.9B

Shares outstanding

382.1M2021-06 374.1M2026-06 382.1M+2.1% over the window

52W low

$4.77

52W high

$13.56

From 52W high

-9.88%

From 52W low

+156.18%

52W range

85%

Volume

Rel volume

0.41×

30D volume

4.8M

30D $ vol

60M

Fundamentals

Sales (ttm)

1.6B2019-12 212.5M2026-06 1.6B+645.7% over the window

Sales/share

$4.152021-12 $1.782026-06 $4.15+132.6% over the window

EPS (ttm)

$0.132021-12 -$937.942026-06 $0.13-100.0% over the window

FCF (ttm)

173.9M2019-12 2.7M2026-06 173.9M+6260.8% over the window

FCF/share

$0.462021-12 -$0.232026-06 $0.46-300.3% over the window

Book value/share

$3.872021-06 $4.132026-06 $3.87-6.3% over the window

Net margin

3.19%2019-12 2.7%2026-06 3.2%+19.7% over the window

ROE

3.43%2021-12 -19.9%2026-06 3.4%-117.2% over the window

ROA

2.32%2021-12 -15.9%2026-06 2.3%-114.6% over the window

Debt / equity

0.18×2021-06 0.102026-06 0.18+72.4% over the window

Current ratio

1.382021-06 3.232026-06 1.38-57.5% over the window

Growth (CAGR, ttm) · 10Y

Sales

+20.40%2025-06-30 → 2026-06-301.3B → 1.6B (+20.4% total)+18.22%2023-06-30 → 2026-06-30959.1M → 1.6B (+65.2% total)+21.21%2021-12-31 → 2026-06-30667.5M → 1.6B (+137.4% total)n/a

FCF

+44.88%2025-06-30 → 2026-06-30120.1M → 173.9M (+44.8% total)n/an/an/a

Shares

-1.77%2025-06-30 → 2026-06-30388.9M → 382.1M (-1.8% total)+0.36%2023-06-30 → 2026-06-30378M → 382.1M (+1.1% total)+0.42%2021-06-30 → 2026-06-30374.1M → 382.1M (+2.1% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+22.57%2025-06-30 → 2026-06-30$3.38 → $4.15 (+22.6% total)+17.80%2023-06-30 → 2026-06-30$2.54 → $4.15 (+63.5% total)+20.65%2021-12-31 → 2026-06-30$1.78 → $4.15 (+132.6% total)n/a

FCF/share

+47.49%2025-06-30 → 2026-06-30$0.31 → $0.46 (+47.4% total)n/an/an/a

Book value/share

+2.03%2025-06-30 → 2026-06-30$3.79 → $3.87 (+2.0% total)-0.75%2023-06-30 → 2026-06-30$3.95 → $3.87 (-2.2% total)-1.30%2021-06-30 → 2026-06-30$4.13 → $3.87 (-6.3% total)n/a

Price

+136.96%2025-10-20 → 2026-10-20$5.16 → $12.22 (+136.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+31.61%2023-10-20 → 2026-10-20$5.36 → $12.22 (+128.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.70%2021-10-20 → 2026-10-20$11.80 → $12.22 (+3.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+136.96%2025-10-20 → 2026-10-20$5.16 → $12.22 (+136.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+31.61%2023-10-20 → 2026-10-20$5.36 → $12.22 (+128.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.70%2021-10-20 → 2026-10-20$11.80 → $12.22 (+3.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

95.3×2021-06 1838.732026-10 92.27-95.0% over the window

Fwd P/E

27.3×

P/S (ttm)Market cap ÷ TTM revenue.

2.9×2021-06 49.052026-10 2.95-94.0% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.2×2021-06 6.752026-10 3.16-53.2% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

26.8×2021-06 3812.652026-10 26.85-99.3% over the window

EV/EBITDA (fy)

40.7×

EV/Sales (ttm)

3.1×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

3.72%2021-12 -2.4%2026-06 4.3%-278.0% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 382.1M ÷ 388.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

1.77%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.77%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

1.77%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($97.6M) ÷ today's market cap ($4.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

2.09%2021-12 0.0%2026-06 2.4%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $97.6M + TTM dividends $0) ÷ today's market cap ($4.7B). Same caveat as the cash buyback yield.

2.09%2021-12 0.0%2026-06 2.4%

Vs own 10Y history

P/S

64th

P/B

92nd